These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3042355)

  • 1. Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension.
    Kaneko Y
    Drugs; 1988; 35 Suppl 6():156-63. PubMed ID: 3042355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of urapidil and atenolol in hypertension.
    Török E; Wagner M; Podmaniczky M
    Drugs; 1988; 35 Suppl 6():164-72. PubMed ID: 3042356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of urapidil in the management of essential hypertension. A comparison with captopril.
    Rosenthal J; Haerlin R; Schäfer N; Christ B; Wurst W
    Drugs; 1988; 35 Suppl 6():147-55. PubMed ID: 3042354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.
    Torvik D; Madsbu HP
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):69S-75S. PubMed ID: 2939870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring.
    Trimarco B; Rosiello G; Feldhaus P; Steinijans VW; Vecchione F; Cuocolo A; Lembo G; Volpe M
    Drugs; 1988; 35 Suppl 6():173-81. PubMed ID: 3402355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects of antihypertensive therapy with urapidil. Comparison with hydrochlorothiazide.
    Distler A; Haerlin R; Hilgenstock G; Passfall J
    Drugs; 1990; 40 Suppl 4():21-7; discussion 28-30. PubMed ID: 2092965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypertensive effect and tolerance to urapidil. Comparison with nifedipine in a multicenter double-blind study].
    Stumpe KO; Feldhaus P; Haerlin R
    Fortschr Med; 1989 Jan; 107(1):54-7. PubMed ID: 2646188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of clinical trials with urapidil.
    Schook CE; Radtke H; Wurst W; Thieme G
    Am J Cardiol; 1989 Aug; 64(7):30D-37D. PubMed ID: 2667312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study.
    Kanniainen E; Heikkilä O; Jääskeläinen T; Lilja M; Jounela AJ
    Eur J Clin Pharmacol; 1985; 28(1):35-9. PubMed ID: 3886400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic assessment of urapidil or angiotensin-converting enzyme inhibition in systemic hypertension.
    Rosenthal J; Haerlin R
    Am J Cardiol; 1989 Aug; 64(7):25D-29D. PubMed ID: 2667311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
    Amodeo C; Barros LM; Batlouni M; Sousa JE
    Arq Bras Cardiol; 1993 Aug; 61(2):127-30. PubMed ID: 8297222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of urapidil in the management of essential hypertension: a comparison with captopril.
    Rosenthal J; Haerlin R
    J Hypertens Suppl; 1988 Dec; 6(2):S69-71. PubMed ID: 3068344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
    Deger G
    Am J Med; 1986 May; 80(5B):62-7. PubMed ID: 2872809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urapidil in patients with severe hypertension and in long-term treatment.
    Takeda T; Kaneko Y; Shionoiri H; Yasuda H; Iimura O; Yoshinaga K; Inagaki Y; Ishii M; Taniguchi K; Mizuno Y
    J Hypertens Suppl; 1988 Dec; 6(2):S37-42. PubMed ID: 2906699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antihypertensive effects of doxazosin: a clinical overview.
    Cox DA; Leader JP; Milson JA; Singleton W
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):83S-90S. PubMed ID: 2939872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the effects of urapidil and methyldopa on left ventricular hypertrophy and haemodynamics in humans.
    Feldstein CA; Olivieri AO; Sabarís RP
    Drugs; 1988; 35 Suppl 6():90-7. PubMed ID: 2969799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of mild hypertension with urapidil or captopril.
    Rosenthal J; Schäfer N; Haerlin R; Wurst W; Solleder P
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):233S-236S. PubMed ID: 3046630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and regional hemodynamic effects of acute and prolonged treatment with urapidil or prazosin in normotensive and spontaneously hypertensive rats.
    Pegram BL; Kobrin I; Natsume T; Gallo AJ; Frohlich ED
    Am J Med; 1984 Oct; 77(4A):64-73. PubMed ID: 6486158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.